Transplant Diagnostics Market: Current Analysis and Forecast (2021-2027)

Transplant diagnostics are tests used to determine whether the donor and receiver of an organ are compatible before or after transplant. The demand for transplant diagnostic products is expected to grow mainly due to factors such as the increasing public-private funding for target research activities, the growing number of organ transplant, and technological advancements in the field of transplant diagnostics. In 2019, the rate of patients having transplanted organs in several nations around the world. During this year, France had a rate of roughly 87 organ transplant patients per million inhabitants. If blood and oxygen are flowing through the organs until the moment of recovery, organ donation can be done by both a deceased and a living donor. The increased rate of organ transplantation is due to the increase in diseases causing severe organ damages. This has been boosting the demand for diagnostic transplants.
Although there are more than 107,453 waiting for organ transplants, there has been a steady rise in the number of donor rates, followed by the deceased donor rate. For instance, as per Global Observatory on Donation and Transplantation (GODT), number of live kidney donors increased by 3.3%b whereas number of deceased donors increased by 8.1% from 2018 to 2019. This shows the improvement and demand for more diagnostics facilities across the healthcare sector related to transplant. The increase in number of organ donors is expected to be very lucrative for growth and dominance of transplant over the forecast period.
In the last decade, healthcare spending in those countries has remained about in line with total economic growth. Between 2010 and 2019, health spending in the OECD averaged around 8.7% of GDP every year. In the same time span, however, healthcare spending in the United States increased from 16.3 percent to 17.0 percent of GDP.
As per OECD data of 2019, the United States accounted for highest per capita GDP of 17% followed by Switzerland and Germany with GDP of 12.1% and 11.7%, respectively. The improvement in healthcare is expected to boost the market for Transplant Diagnostics Market.
Bio-Rad laboratories, Inc., Dorel Industries Inc., F. Hoffman-La Roche Ltd., QIAGEN N.V., Thermo Fisher Scientific Inc., bioMérieux S.A., Immucor, Inc., llumina, Inc., Luminex Corporation, Becton, Dickinson and Company, are some of the prominent players operating in the global Transplant Diagnostics market. Several M&A’s along with partnerships have been undertaken by these players to facilitate costumers with hi-tech and innovative products.
Insights Presented in the Report
“Amongst Technology, Molecular Assay Technologies segment holds the major share”
Based on technology, the market is fragmented into molecular assay technologies, and non-molecular assay technologies. Further, the molecular technologies studied into PCR-based molecular assays, sequencing based molecular assays. The molecular assay technologies segment dominated the market with a share of XX% in 2020 and is expected to maintain its dominance during the forecast period owing to the increasing public-private financing for target research efforts and the expanding burden of infectious illnesses.
“Amongst Product & Service, Instruments is anticipated to grow at the highest CAGR during the analyzed period”
Further based on product & service, the market is fragmented into reagents & consumables, instruments, software & services. In 2020, instruments accounted for a maximum market revenue share of XX% and is expected to remain dominant during the analyzed period owing to the increasing healthcare expenditures.
Amongst Transplant Type, Solid Organ Transplantation segment holds the major share”
Based on the transplant type, the market is fragmented into solid organ transplantation stem cell transplantation, soft tissue transplantation, and bone marrow transplantation. The solid organ transplantation centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period. Furthermore, the segment is also expected to grow at the highest CAGR during the period.
Amongst Application, Diagnostic Application segment holds the major share”
Based on the application, the market is fragmented into diagnostic applications and research applications. The diagnostic applications centers dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period on account of its varied applications in patient profiling and increasing clinical evidence of its efficacy.
Amongst End-User, Independent Reference Laboratories segment holds the major share”
Based on the end-user type, the market is fragmented into independent reference laboratories, hospitals & transplant centers, and research laboratories & academic institutes. The independent reference laboratories dominated the market in 2020 with revenue of USD XX billion and is anticipated to maintain its dominance during the analyzed period owing to the growing number of research & development activities outsourced by pharmaceutical & biotechnology companies to independent reference laboratories.
“North America signifies one of the largest markets of Transplant Diagnostics Market”
For a better understanding of the market dynamics of the Transplant Diagnostics market, a detailed analysis was conducted for different regions across the globe including North America (United States, Canada, and the Rest of North America), Europe (Germany, France, Italy, Spain, United Kingdom and Rest of Europe), Asia-Pacific (China, Japan, India, and Rest of APAC), Rest of World has been conducted. North America dominated the market and generated revenue of USD XX billion in 2020 owing to factors such as highly developed healthcare infrastructure and the availability of skilled professionals. Moreover, the high adoption of personalized medicines, stem cell therapies, and soft tissue transplants are augmenting the regional market growth. Although there are 107,453 of individuals are in the waiting list waiting list in USA but at the same time the number of donors are also increasing at a good pace.
Reasons to buy this report:
• The study includes market sizing and forecasting analysis validated by authenticated key industry experts
• The report presents a quick review of overall industry performance at one glance
• The report covers an in-depth analysis of prominent industry peers with a primary focus on key business financials, product portfolio, expansion strategies, and recent developments
• Detailed examination of drivers, restraints, key trends, and opportunities prevailing in the industry
• The study comprehensively covers the market across different segments
• Deep dive regional level analysis of the industry
Customization Options:
The Transplant Diagnostics Market can further be customized as per the requirement or any other market segment. Besides this, understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.